Correlation Between NeuPath Health and INTEL CDR

Can any of the company-specific risk be diversified away by investing in both NeuPath Health and INTEL CDR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuPath Health and INTEL CDR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuPath Health and INTEL CDR, you can compare the effects of market volatilities on NeuPath Health and INTEL CDR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuPath Health with a short position of INTEL CDR. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuPath Health and INTEL CDR.

Diversification Opportunities for NeuPath Health and INTEL CDR

-0.35

Correlation Coefficient

NeuPath Health  INTEL CDR

Very good diversification

The 3 months correlation between NeuPath and INTEL is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding NeuPath Health and INTEL CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INTEL CDR and NeuPath Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuPath Health are associated (or correlated) with INTEL CDR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INTEL CDR has no effect on the direction of NeuPath Health i.e., NeuPath Health and INTEL CDR go up and down completely randomly.

Pair Corralation between NeuPath Health and INTEL CDR

Assuming the 90 days trading horizon NeuPath Health is expected to generate 1.9 times less return on investment than INTEL CDR. But when comparing it to its historical volatility, NeuPath Health is 1.1 times less risky than INTEL CDR. It trades about 0.04 of its potential returns per unit of risk. INTEL CDR is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,164  in INTEL CDR on December 30, 2024 and sell it today you would earn a total of  159.00  from holding INTEL CDR or generate 13.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NeuPath Health  vs.  INTEL CDR

NeuPath Health

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, NeuPath Health may actually be approaching a critical reversion point that can send shares even higher in April 2025.

INTEL CDR

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in INTEL CDR are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, INTEL CDR exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeuPath Health and INTEL CDR

The main advantage of trading using opposite NeuPath Health and INTEL CDR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuPath Health position performs unexpectedly, INTEL CDR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INTEL CDR will offset losses from the drop in INTEL CDR's long position.

The idea behind NeuPath Health and INTEL CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.